Kronox Lab Sciences Ltd
Kronox Lab Sciences Ltd (KRONOX) last reported results for the quarter ended Jun 2026, with sales of ₹28.39 crore and net profit of ₹7.3 crore. The next scheduled event is a merger acquisition on 15 Oct 2026. The stock last traded at ₹207, a market capitalisation of ₹768 crore, on a P/E of 26.9. Over the past 52 weeks the stock has ranged between ₹96 and ₹228. Figures are as of 6 Oct 2026 and are not real time.
Kronox Lab Sciences Ltd share price and key metrics
- Current price
- ₹207
- Market cap
- ₹768 cr
- Stock P/E
- 26.9
- Book value
- ₹31.3
- ROE
- 26.8%
- ROCE
- 36.0%
- Dividend yield
- 0.25%
- 52w high / low
- 228/96.0
Metrics as of 6 Oct 2026. Not real time.
Track Kronox Lab Sciences Ltd
Cruxal reads every Kronox Lab Sciences Ltd filing as it lands, scores what it means for the stock, and emails you the ones that matter. Free to start.
Kronox Lab Sciences Ltd growth and returns
- 10 Years
- %
- 5 Years
- 10%
- 3 Years
- 2%
- TTM
- 6%
- 10 Years
- %
- 5 Years
- 23%
- 3 Years
- 19%
- TTM
- 12%
- 10 Years
- %
- 5 Years
- %
- 3 Years
- %
- 1 Year
- 26%
- 10 Years
- %
- 5 Years
- 33%
- 3 Years
- 31%
- Last Year
- 27%
Kronox Lab Sciences Ltd quarterly results
In the quarter ended Jun 2026, sales were ₹28.39 cr, up 16.9% from ₹24.29 cr a year earlier. Net profit was ₹7.3 cr, up 16.2% year on year.
| ₹ crore | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Sales | 24.86 | 24.01 | 26.13 | 24.29 | 25.53 | 25.27 | 26.13 | 28.39 |
| Expenses | 16.06 | 15.65 | 18.38 | 16.32 | 16.88 | 17.24 | 16.61 | 19.4 |
| Operating profit | 8.8 | 8.36 | 7.75 | 7.97 | 8.65 | 8.03 | 9.52 | 8.99 |
| OPM % | 35.40% | 34.82% | 29.66% | 32.81% | 33.88% | 31.78% | 36.43% | 31.67% |
| Other income | 0.36 | 0.82 | 0.91 | 0.87 | 1.04 | 1.13 | 2.15 | 1.3 |
| Interest | 0 | 0 | 0 | 0 | 0.04 | 0.04 | 0.04 | 0.03 |
| Depreciation | 0.34 | 0.36 | 0.35 | 0.4 | 0.47 | 0.52 | 0.66 | 0.45 |
| Profit before tax | 8.82 | 8.82 | 8.31 | 8.44 | 9.18 | 8.6 | 10.97 | 9.81 |
| Tax % | 26.64% | 26.08% | 24.07% | 25.71% | 27.23% | 23.37% | 26.98% | 25.59% |
| Net profit | 6.47 | 6.53 | 6.32 | 6.28 | 6.68 | 6.59 | 8 | 7.3 |
| EPS (₹) | 1.74 | 1.76 | 1.70 | 1.69 | 1.80 | 1.78 | 2.16 | 1.97 |
Consolidated figures as reported by the company. Percentages are as published; totals may not sum exactly.
Kronox Lab Sciences Ltd annual results
| ₹ crore | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|
| Sales | 50 | 62 | 82 | 96 | 90 | 100 | 101 | 105 |
| Operating profit | 12 | 15 | 20 | 22 | 28 | 33 | 34 | 35 |
| OPM % | 23% | 24% | 24% | 23% | 32% | 33% | 34% | 33% |
| Net profit | 9 | 10 | 14 | 16 | 21 | 25 | 28 | 29 |
| EPS (₹) | 343.60 | 403.73 | 565.56 | 4.42 | 5.75 | 6.86 | 7.45 | 7.71 |
TTM is the trailing twelve months to the most recent quarter.
Kronox Lab Sciences Ltd balance sheet
| ₹ crore | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|
| Equity capital | 0.25 | 0.24 | 0.24 | 37 | 37 | 37 | 37 |
| Reserves | 23 | 27 | 40 | 8 | 29 | 53 | 79 |
| Borrowings | 0 | 4 | 3 | 0 | 0 | 0 | 2 |
| Other liabilities | 11 | 7 | 13 | 9 | 8 | 9 | 10 |
| Total liabilities | 34 | 38 | 57 | 54 | 74 | 99 | 128 |
| Fixed assets | 6 | 9 | 11 | 16 | 26 | 28 | 29 |
| CWIP | 0 | 0 | 0 | 0 | 0 | 1 | 1 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other assets | 29 | 28 | 45 | 38 | 47 | 70 | 98 |
| Total assets | 34 | 38 | 57 | 54 | 74 | 99 | 128 |
As reported by the company. Total assets equal total liabilities by construction.
Kronox Lab Sciences Ltd cash flow
| ₹ crore | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|
| Cash from operations | 4 | 11 | 9 | 20 | 17 | 31 | 24 |
| Cash from investing | -4 | -3 | -8 | -7 | -17 | -28 | -24 |
| Cash from financing | -0 | -7 | -1 | -13 | 0 | -2 | -0 |
| Net cash flow | 0 | 1 | 1 | -0 | 0 | 0 | -0 |
| Free cash flow | 3 | 10 | 5 | 11 | 5 | 28 | 21 |
| CFO / operating profit | 65% | 100% | 70% | 117% | 87% | 120% | 98% |
Negative figures are outflows. CFO / operating profit is a ratio, not an amount.
Kronox Lab Sciences Ltd operating ratios
| Per year | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|
| ROCE % | — | 50% | 51% | 50% | 52% | 44% | 36% |
| Debtor days | 110 | 90 | 114 | 71 | 72 | 72 | 76 |
| Inventory days | 70 | 58 | 58 | 61 | 74 | 47 | 66 |
| Days payable | 102 | 69 | 89 | 52 | 51 | 54 | 52 |
| Cash conversion cycle | 78 | 79 | 84 | 80 | 94 | 66 | 90 |
| Working capital days | 100 | 95 | 122 | 83 | 143 | 65 | 71 |
Ratios as computed by the source from the reported statements. Rows a company does not report are omitted.
Kronox Lab Sciences Ltd shareholding pattern
Promoters held 74.21% at Jun 2026, broadly unchanged since Jun 2025. FIIs 0.04% and DIIs 2.07%.
| % held | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Promoters | 74.21% | 74.21% | 74.21% | 74.21% | 74.21% | 74.21% | 74.21% | 74.21% |
| FIIs | 0.56% | 0.49% | 0.05% | 0.03% | 0.03% | 0.05% | 0.08% | 0.04% |
| DIIs | 2.57% | 2.20% | 2.20% | 1.71% | 1.93% | 2.00% | 2.05% | 2.07% |
| Public | 22.66% | 23.10% | 23.54% | 24.04% | 23.84% | 23.74% | 23.66% | 23.68% |
| No. of shareholders | 39,792 | 38,489 | 37,922 | 37,569 | 35,780 | 34,608 | 33,469 | 32,479 |
As disclosed by the company to the exchanges. The last row is a count of shareholders, not a percentage.
Upcoming Kronox Lab Sciences Ltd events
The next scheduled event is a merger acquisition on 15 Oct 2026.
- Merger acquisitionOpen offer for acquisition of 25.79% equity shares of Kronox Lab Sciences Ltd by Indo Borax and Chemicals Limited
See the full results calendar for every Indian company reporting in the next 30 days.
Cruxal coverage of Kronox Lab Sciences Ltd
Kronox Lab Sciences Ltd corporate filings
- Compliance Certificate under Regulation 74(5) of SEBI (DP) Regulations, 2018Company Updatelow impact
- Kronox Lab Sciences Ltd files Regulation 7(2) disclosure; no financial or operational changes reportedCompany Updatelow impact
Cruxal's analysis: The company has submitted a regulatory disclosure under SEBI PIT regulations on October…
Read the full analysis - Kronox Lab Sciences Limited completes substantial acquisition of Zenrock Chemicals Private Limited, acquiring 23.088% stake via share purchase agreementInsider Trading / SASThigh impact
Cruxal's analysis: Kronox Lab Sciences Limited has announced the completion of a significant share…
Read the full analysis - Major Share Sale: Kronox Lab Sciences Limited Discloses Sale of 85.66 Lakh Shares (23.09% Stake) to Indo Borax & Chemicals Limited, Impacting 2026 Shareholding StructureInsider Trading / SASThigh impact
Cruxal's analysis: Kronox Lab Sciences Limited announced the sale of 85.66 lakh equity shares (23.09% of…
Read the full analysis - Kronox Lab Sciences Limited acquires 23.088% stake in its own equity via share purchase agreement, indicating strategic ownership restructuringInsider Trading / SASTmedium impact
Cruxal's analysis: Kronox Lab Sciences Limited announced a significant share acquisition, purchasing 85.66…
Read the full analysis - Kronox Lab Sciences completes acquisition of Zenrock Chemicals with 2.38 crore equity shares, representing 64.26% stake, via share purchase agreement dated September 29, 2026Insider Trading / SASThigh impact
Cruxal's analysis: Kronox Lab Sciences has announced the acquisition of Zenrock Chemicals Private Limited…
Read the full analysis - SEBI Disclosure: Indicating Acquisition of 64.26% Stake in Kronox Lab Sciences Limited by Indo Borax & Chemicals LimitedInsider Trading / SASThigh impact
Cruxal's analysis: Indo Borax & Chemicals Limited has disclosed acquiring a 64.26% stake in Kronox Lab…
Read the full analysis - Intimation under Regulation 31(A) of SEBI (LODR) Regulations, 2015Company Updatelow impact
- Outcome of Board MeetingOthersmedium impact
- Closure of Trading Window for the Quarter and half year ending September, 2026Insider Trading / SASTlow impact
- Kronox Lab Sciences Limited Announces Successful Conclusion of 17th Annual General Meeting and Dividend ApprovalAGM/EGMlow impact
Cruxal's analysis: Kronox Lab Sciences Limited has successfully concluded its 17th Annual General Meeting…
Read the full analysis - Kronox Lab Sciences Limited Announces Successful Conclusion of 17th AGM and Approval of Final DividendAGM/EGMlow impact
Cruxal's analysis: Kronox Lab Sciences Limited has successfully concluded its 17th Annual General Meeting…
Read the full analysis - Kronox Lab Sciences Limited concludes 17th Annual General Meeting; declares final dividend of INR 0.50 per shareAGM/EGMlow impact
Cruxal's analysis: Kronox Lab Sciences Limited has successfully concluded its 17th Annual General Meeting…
Read the full analysis - Indo Borax and Chemicals Limited Announces Open Offer for 25.79% Stake in Kronox Lab Sciences Limited at INR 157.27 per ShareCompany Updatehigh impact
Cruxal's analysis: Indo Borax and Chemicals Limited, along with Zenrock Chemicals Private Limited, has filed…
Read the full analysis - Kronox Lab Sciences Ltd schedules 17th Annual General Meeting for September 16, 2026Company Updatelow impact
Cruxal's analysis: Kronox Lab Sciences Ltd has issued a newspaper publication announcing its 17th Annual…
Read the full analysis - Indo Borax and Chemicals Limited Announces Open Offer to Acquire 25.79% Stake in Kronox Lab Sciences LimitedCompany Updatehigh impact
Cruxal's analysis: Kronox Lab Sciences Limited has received a Detailed Public Statement regarding an open…
Read the full analysis - Indo Borax and Chemicals Limited Announces Mandatory Open Offer for Kronox Lab Sciences LimitedCompany Updatehigh impact
Cruxal's analysis: Indo Borax and Chemicals Limited, along with Zenrock Chemicals Private Limited, has…
Read the full analysis - Kronox Lab Sciences Limited fixes September 09, 2026, as record date for final dividend of INR 0.50 per shareCorp. Actionlow impact
Cruxal's analysis: Kronox Lab Sciences Limited has officially announced Wednesday, September 09, 2026, as…
Read the full analysis - Kronox Lab Sciences Limited Announces 17th Annual General Meeting for September 16, 2026AGM/EGMlow impact
Cruxal's analysis: Kronox Lab Sciences Limited has scheduled its 17th Annual General Meeting (AGM) for…
Read the full analysis - Kronox Lab Sciences Ltd submits revised Annual Report for FY 2025-26Otherslow impact
Cruxal's analysis: Kronox Lab Sciences has filed a revised version of its Annual Report for the financial…
Read the full analysis
This page shows filings on a one-hour delay. Sign in to see them as they land, with Cruxal's analysis of what each one means.
Cruxal publishes market data and coverage for information only. Nothing here is investment advice.